Ian Hamilton shares his thoughts on the new Drug Use series published yesterday in The Lancet: The global drug problem – change but not progression.
[read the full story...]The global drug problem: who cares? #LxAddictions19
No Responses »
Medication for ADHD: what works for adults, adolescents and children
Dean Connolly is impressed by a recent systematic review and network meta-analysis, which compares the efficacy and tolerability of medication for ADHD in children, young people and adults.
[read the full story...]Novel Psychoactive Substances: bridging the knowledge gap
Derek Tracy takes a first look at the Novel Psychoactive Substances in the UK Project; an NIHR-funded empirical and conceptual review that recommends research priorities in the field.
[read the full story...]Novel Psychoactive Substances: important information for health professionals
Harry Sumnall, Ian Hamilton and Mark Monaghan provide an overview of Novel Psychoactive Substances (NPS) aimed at health professionals and others who work with people who use these new psychoactive substances.
[read the full story...]Cardiovascular safety of methylphenidate
Samuele Cortese considers the findings of a recent nationwide self controlled case series study of the cardiovascular safety of methylphenidate use in children and young people with ADHD.
[read the full story...]Amphetamines and methylphenidate for paediatric ADHD: meta-analysis of n-of-1 trials
Samuele Cortese publishes his debut Mental Elf blog on a meta-analysis of n-of-1 trials, which shows that amphetamine derivatives and methylphenidate are superior to placebo, in the short term, for paediatric ADHD.
[read the full story...]Methylphenidate for ADHD: have Cochrane got it wrong this time?
Chris Hollis appraises a recent Cochrane systematic review, which casts doubt over the quality of trial evidence and the clinical effectiveness of Methylphenidate for ADHD.
[read the full story...]Commonly prescribed psychiatric drugs: do they work?
John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.
[read the full story...]Stimulants reduce risk of injuries in children with ADHD
Joff Jones highlights an important public health finding from a recent prospective cohort study about the effect of stimulant drugs on the risk of injuries in children with ADHD.
[read the full story...]Combined methylphenidate and citalopram may help older people with depression recover faster
Lisa Burscheidt summarises a recent randomised controlled trial of combined methylphenidate and citalopram for depression in older people, which presents promising but limited findings.
[read the full story...]